Early diagnosis of Usher syndrome type 1 made possible by new findings

May 02, 2003

Bethesda, Maryland - Deafness in both ears and progressive loss of vision due to retinitis pigmentosa are the indicators of Usher syndrome, a genetic dual deficit disorder. There are three clinical subtypes of Usher syndrome, the most severe of which is Usher type 1 (USH1). This syndrome involves deafness at birth, progressive blindness and balance problems. In 1861, a physician working in Berlin described the clinical features of Usher syndrome in Jewish individuals. Now, 140 years later, there is an opportunity to offer help to those individuals who inherit this syndrome as reported in the April 24, 2003 New England Journal of Medicine.

A significant collaboration across four institutions was led by scientists at the National Institute on Deafness and Other Communication Disorders at the National Institutes of Health including Thomas B. Friedman, Ph.D., Chief, Laboratory of Molecular Genetics, Tamar Ben-Yosef, Ph.D., the key scientist on this project, and Andrew J. Griffith, M.D., Ph.D. Additional collaborators on this project were Seth Ness, M.D., Ph.D., Mount Sinai School of Medicine, Karen Avraham, Ph.D. at the Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, and Harry Ostrer, M.D., and Carole Oddoux, Ph.D. at the Department of Molecular Genetics, NYU Medical Center.

Dr. Ben-Yosef identified a mutation, R245X, of an Usher syndrome type 1 gene, PCDH15, which appears to account for a large proportion of USH1 in the Ashkenazi Jewish population today. Ashkenazi describes those Jewish people who came from eastern Europe.

In earlier studies in Dr. Friedman's laboratory, a founder mutation, 167delT, was identified in the GJB2 gene, which is carried by 4% of Ashkenazi Jewish individuals. It is one of the major causes of autosomal-recessive, nonsyndromic hearing loss in the same population. Dr. Friedman hypothesized that at least one USH1 mutation, which arose in an ancestral population, is a significant cause of current USH1.

Dr. Friedman noted, "Using DNA contributions from affected families in the United States and Israel, we searched for a haplotype of genetic markers closely linked to any of six reported USH1 loci in families of Ashkenazi Jewish descent."

This approach allowed identification of the R245X founder mutation. They found high carrier frequencies of R245X in the Ashkenazi Jewish population. Carriers are individuals who, although having no symptoms of the disorder, transmit their single copy of the disabled gene to their descendants.

There are no data to indicate that there is an increased frequency of Usher syndrome in this population, only that the inheritance of the disorder is more clearly identifiable. There is indication, through the study's controls of other non-Ashkenazi Jewish and non-Jewish populations, that this mutation may be unique to the Ashkenazi population.

Uncovering the R245X mutation as a significant cause of USH1 in Ashkenazi Jewish individuals, means there are diagnostic and intervention strategies that can be helpful in ameliorating the devastation of this disorder.

"Knowledge is truly empowerment in this case," noted James F. Battey, M.D., Ph.D., Director of the National Institute on Deafness and Other Communication Disorders. "Molecular diagnosis, carrier screening, and genetic counseling all will lead to earlier intervention for a child who will be challenged by hearing loss and progressive blindness, while he or she can still take advantage of the sensory input still available in the earlier years."

Molecular screening is an important tool for use with children in this population, who are born with bilateral, profound hearing loss, not associated with GJB2 mutations. From these finding, it has become clear that these children should be tested for R245X and have ophthalmologic evaluation, including funduscopic examination and electroretinography. These evaluations will detect retinitis pigmentosa at a presymptomatic state. From this early identification, the child who is an appropriate candidate and who has the ability to see and read lips for some 10-12 years pre-onset of the blindness, would be able to benefit from a cochlear implant. "We are especially concerned that a deaf infant who will eventually lose his or her sight not be without appropriate support or intervention," said Friedman.

A cochlear implant is a small, complex electronic device. The implant is surgically implanted under the skin behind the ear and, with the use of a highly sensitive speech processor, can provide a sense of interpretable sound to a profoundly deaf or severely hearing impaired.

Carrier screening and genetic counseling will allow parents to prepare for the educational and social needs of a child who has Usher syndrome type I and for his or her progressive loss of sight. Parents will be able to focus on communication skills that will be needed by their child.

Screening for R245X would allow additional information to be provided to individuals who will already be screened for Tay-Sachs, Gaucher and Canavan diseases as they seek to have more information about their genetic history.

In discussing the finding, Dr. Battey said, "This is a highly important discovery. When a mutation has a high carrier frequency in a population and we can identify it, basic science translates directly to clinical possibility for these children."
The National Institute on Deafness and Other Communication Disorders is an Institute of the National Institutes of Health, within the Department of Health and Human Services. NIDCD supports and conducts research and research training on the normal processes and diseases and disorders of human communication that affect millions of Americans.

The Department of Human Genetics at the Mount Sinai School of Medicine is a hybrid basic science and clinical department that offers a broad-based program of instruction, research, and clinical services in human genetics. (http://www.mssm.edu/genetics/introduction.shtml)

The Sackler Faculty of Medicine is Israel's largest institute of higher medical education. (http://www.tau.ac.il/medicine/about.html)

New York University Medical Center (www.med.nyu.edu).

Reporters, to interview Dr. Friedman, Dr. Battey, Dr. Ben-Yosef, or Dr. Griffith or for more background on the research, please contact the Office of Health Communication and Public Liaison, NIDCD at 301-496-7243 (phone) or 301-402-0018 (fax).

Dr. Ness: 212-426-9065; 917-641-1432 (pager), Mt. Sinai
Dr. Avraham: 972-3-640-7030, Sackler
Dr. Ostrer: 212-263-7596; 212-263-5746 (pager), NYU

NIH/National Institute on Deafness and Other Communication Disorders

Related Hearing Loss Articles from Brightsurf:

Proof-of-concept for a new ultra-low-cost hearing aid for age-related hearing loss
A new ultra-affordable and accessible hearing aid made from open-source electronics could soon be available worldwide, according to a study published September 23, 2020 in the open-access journal PLOS ONE by Soham Sinha from the Georgia Institute of Technology, Georgia, US, and colleagues.

Ultra-low-cost hearing aid could address age-related hearing loss worldwide
Using a device that could be built with a dollar's worth of open-source parts and a 3D-printed case, researchers want to help the hundreds of millions of older people worldwide who can't afford existing hearing aids to address their age-related hearing loss.

Understanding the link between hearing loss and dementia
Scientists have developed a new theory as to how hearing loss may cause dementia and believe that tackling this sensory impairment early may help to prevent the disease.

Study uncovers hair cell loss as underlying cause of age-related hearing loss
In a study of human ear tissues, scientists have demonstrated that age-related hearing loss is mainly caused by damage to hair cells.

Hair cell loss causes age-related hearing loss
Age-related hearing loss has more to do with the death of hair cells than the cellular battery powering them wearing out, according to new research in JNeurosci.

How hearing loss in old age affects the brain
If your hearing deteriorates in old age, the risk of dementia and cognitive decline increases.

Examining associations between hearing loss, balance
About 3,800 adults 40 and older in South Korea participating in a national health survey were included in this analysis that examined associations between hearing loss and a test of their ability to retain balance.

Veterinarians: Dogs, too, can experience hearing loss
Just like humans, dogs are sometimes born with impaired hearing or experience hearing loss as a result of disease, inflammation, aging or exposure to noise.

Victorian child hearing-loss databank to go global
A unique databank that profiles children with hearing loss will help researchers globally understand why some children adapt and thrive, while others struggle.

Hearing loss, dementia risk in population of Taiwan
A population-based study using data from the National Health Insurance Research Database of Taiwan suggests hearing loss is associated with risk of dementia.

Read More: Hearing Loss News and Hearing Loss Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.